Spots Global Cancer Trial Database for relapsed, refractory
Every month we try and update this database with for relapsed, refractory cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults | NCT02535806 | Acute Lymphobla... Lymphoblastic L... | Velcade Methotrexate Methotrexate / ... Dexamethasone Mitoxantrone Vincristine Pegaspargase | 1 Year - 39 Years | Children's Mercy Hospital Kansas City | |
Phase 1/2 Study of REGN5458 in Adult Patients With Relapsed or Refractory Multiple Myeloma | NCT03761108 | Multiple Myelom... | Linvoseltamab | 18 Years - | Regeneron Pharmaceuticals | |
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN | NCT03386513 | Blastic Plasmac... Myeloproliferat... | IMGN632 | 18 Years - | ImmunoGen, Inc. | |
Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults | NCT02535806 | Acute Lymphobla... Lymphoblastic L... | Velcade Methotrexate Methotrexate / ... Dexamethasone Mitoxantrone Vincristine Pegaspargase | 1 Year - 39 Years | Children's Mercy Hospital Kansas City |